Injectable administration limits convenience and acceptance for some patients
Alexander JJ
Luteolin alleviates non-alcoholic fatty liver disease in rats via restoration of intestinal mucosal barrier damage and microbiota imbalance involving in gut-liver axis
GHRP2 Moderate GH release potency Mild appetite stimulation Short half-life (~1530 minutes) Can slightly raise cortisol and prolactin in high doses Strong synergy with CJC1295 (no DAC) Balanced option for fat loss, recovery, and moderate anabolic effect GHRP2 effectively stimulates GH release while minimizing the exaggerated hunger response seen with GHRP6. Patel et al., Endocrinology and Metabolism Clinics GHRP6 High appetite stimulation due to intense ghrelin mimicry Comparable GH release to GHRP2 Also short-acting May be useful for bulking or individuals needing to gain weight Known for causing intense hunger post-injection The ghrelin-like hunger response of GHRP6 may be too pronounced for those focused on fat loss or weight control. Nagaya et al., The Journal of Clinical Investigation Ipamorelin Selective GH secretagogue with minimal side effects Does not elevate cortisol or prolactin Longer half-life (~2 hours), smoother release No significant impact on appetite Preferred for fat loss and long-term hormone optimization Ipamorelin demonstrates high specificity for GH release without the off-target hormonal elevation seen with other GHRPs. Miljic et al., The Journal of Endocrinological Investigation Summary Comparison: Potential Side Effects of GHRP2 and How to Manage Them While GHRP2 is generally well-toleratedespecially when used at beginner dosesit can still produce side effects, particularly if dosed too frequently or at high concentrations
Li JJ, Zeng Z, Chang YJ, et al
The drugs appeared to specifically target the motivational drive to seek rewarding substances
